Clinical Trials List
Protocol NumberNVL-655-01
Active
2023-04-01 - 2025-12-31
Phase I/II
Not yet recruiting2
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 吳尚俊 Division of General Internal Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- 蔡子修 Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- YEN-TING LIN Division of General Internal Medicine
- JIN-YUAN SHIH Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- Wei-Wu Chen Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 徐偉勛 醫學研究部
- 廖唯昱 Division of General Internal Medicine
- Jih-Hsiang Lee Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Chian-Wei Chen Division of General Internal Medicine
- Wu-Chou Su Division of Hematology & Oncology
- Chin-Wei Kuo Division of General Internal Medicine
- Yi-Ting Yen
- Chun-Hui Lee Division of Hematology & Oncology
- Seu-Chun Yang Division of General Internal Medicine
- 蔡政軒 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
23 participants
-
Global
840 participants
